James Telfser s Top Picks: April 20, 2021
Morgan Stanley joins bank bond bonanza with three-part sale
John Zechner s Top Picks: April 19, 2021
Teslaâs fiery crash adds to drag on already wobbly EV stocks
An ether ETF isn t even launched and already there is a fee war
Tech leads stock drop from record; dollar falls
Wall Street canât stop smashing records while pandemic lingers
Greg Newman s Top Picks: April 16, 2021
Family offices are targeting 800% returns with SPAC economics
Ark Invest s Cathie Wood thinks Shopify could be next Amazon
Christine Poole s Top Picks: April 15, 2021
Cooler heads prevailed (mostly) during COVID market mayhem: Survey
Coinbase rallies as Wall Street optimism bucks Bitcoinâs dip
FDA Seeks a New Way to Review Old Drugs Without Causing Prices to Soar physiciansweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from physiciansweekly.com Daily Mail and Mail on Sunday newspapers.
The FDA seeks a new way to review old drugs without causing prices to soar
Chuck Peterson of Omaha, Nebraska, recently experienced a swollen, painful knuckle caused by arthritis. He got a prescription for colchicine.
Doctors have used the drug for treating gout and other rheumatic conditions for well over two centuries.
When Peterson went to the pharmacy, he was shocked to discover that a two-month supply of 120 pills, distributed by Par Pharmaceutical, would cost him $225 out-of-pocket on his Medicare Part D drug plan. Taking it for an additional three months, as his rheumatologist wanted him to do, would cost him nearly $600 under his drug plan.
Endo to Announce Fourth-Quarter and Full-Year 2020 Financial Results newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.